CEOP-R regimen

Revision as of 13:48, 11 March 2015 by Aparna Vuppala (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for CEOP-R regimen

Articles

Most recent articles on CEOP-R regimen

Most cited articles on CEOP-R regimen

Review articles on CEOP-R regimen

Articles on CEOP-R regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CEOP-R regimen

Images of CEOP-R regimen

Photos of CEOP-R regimen

Podcasts & MP3s on CEOP-R regimen

Videos on CEOP-R regimen

Evidence Based Medicine

Cochrane Collaboration on CEOP-R regimen

Bandolier on CEOP-R regimen

TRIP on CEOP-R regimen

Clinical Trials

Ongoing Trials on CEOP-R regimen at Clinical Trials.gov

Trial results on CEOP-R regimen

Clinical Trials on CEOP-R regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CEOP-R regimen

NICE Guidance on CEOP-R regimen

NHS PRODIGY Guidance

FDA on CEOP-R regimen

CDC on CEOP-R regimen

Books

Books on CEOP-R regimen

News

CEOP-R regimen in the news

Be alerted to news on CEOP-R regimen

News trends on CEOP-R regimen

Commentary

Blogs on CEOP-R regimen

Definitions

Definitions of CEOP-R regimen

Patient Resources / Community

Patient resources on CEOP-R regimen

Discussion groups on CEOP-R regimen

Patient Handouts on CEOP-R regimen

Directions to Hospitals Treating CEOP-R regimen

Risk calculators and risk factors for CEOP-R regimen

Healthcare Provider Resources

Symptoms of CEOP-R regimen

Causes & Risk Factors for CEOP-R regimen

Diagnostic studies for CEOP-R regimen

Treatment of CEOP-R regimen

Continuing Medical Education (CME)

CME Programs on CEOP-R regimen

International

CEOP-R regimen en Espanol

CEOP-R regimen en Francais

Business

CEOP-R regimen in the Marketplace

Patents on CEOP-R regimen

Experimental / Informatics

List of terms related to CEOP-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Cyclophosphamide/Epirubicin/Vincristine/Prednisone

Overview

CEOP-R regimen refers to an immunochemotherapy regimen consisting of cyclophosphamide, epirubicin, vincristine (Oncovin), prednisone and rituximab used to treat both indolent and aggressive forms of Diffuse large B-cell lymphoma.[1]

Regimen

C – Cyclophosphamide

E – Epirubicin

O – Vincristine (Oncovin)

P – Prednisone

R – Rituximab

Indications

References

  1. 1.0 1.1 Li Y, Yimamu M, Wang X, Zhang X, Mao M, Fu L; et al. (2014). "Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression". Int J Hematol. 99 (1): 79–86. doi:10.1007/s12185-013-1472-z. PMID 24258714.